Search results:

Gene ID	Symbol	Synonyms	Official Full Name	Location
The pahtway p2685 has 66 genes in the original annotation. Currently, there are 48 genes in SZGR (with evidence in schizophrenia) that are present at this pathway.
6387	CXCL12	IRH \| PBSF \| SCYB12 \| SDF1 \| TLSF \| TPAR1	C-X-C motif chemokine ligand 12	10q11.1
983	CDK1	CDC2 \| CDC28A \| P34CDC2	cyclin-dependent kinase 1	10q21.1
1027	CDKN1B	CDKN4 \| KIP1 \| MEN1B \| MEN4 \| P27KIP1	cyclin-dependent kinase inhibitor 1B	12p13.1-p12
928	CD9	BTCC-1 \| DRAP-27 \| MIC3 \| MRP-1 \| TSPAN-29 \| TSPAN29	CD9 molecule	12p13.3
599	BCL2L2	BCL-W \| BCL2-L-2 \| BCLW \| PPP1R51	BCL2 like 2	14q11.2-q12
2353	FOS	AP-1 \| C-FOS \| p55	FBJ murine osteosarcoma viral oncogene homolog	14q24.3
863	CBFA2T3	ETO2 \| MTG16 \| MTGR2 \| ZMYND4	core-binding factor, runt domain, alpha subunit 2; translocated to, 3	16q24
6776	STAT5A	MGF \| STAT5	signal transducer and activator of transcription 5A	17q11.2
6352	CCL5	D17S136E \| RANTES \| SCYA5 \| SIS-delta \| SISd \| TCP228 \| eoCP	C-C motif chemokine ligand 5	17q12
6774	STAT3	ADMIO \| APRF \| HIES	signal transducer and activator of transcription 3 (acute-phase response factor)	17q21.31
3690	ITGB3	BDPLT16 \| BDPLT2 \| CD61 \| GP3A \| GPIIIa \| GT	integrin subunit beta 3	17q21.32
596	BCL2	Bcl-2 \| PPP1R50	B-cell CLL/lymphoma 2	18q21.3
3727	JUND	AP-1	jun D proto-oncogene	19p13.2
6915	TBXA2R	BDPLT13 \| TXA2-R	thromboxane A2 receptor	19p13.3
898	CCNE1	CCNE \| pCCNE1	cyclin E1	19q12
7040	TGFB1	CED \| DPD1 \| LAP \| TGFB \| TGFbeta	transforming growth factor beta 1	19q13.1
6886	TAL1	SCL \| TCL5 \| bHLHa17 \| tal-1	T-cell acute lymphocytic leukemia 1	1p32
4352	MPL	C-MPL \| CD110 \| MPLV \| THCYT2 \| TPOR	MPL proto-oncogene, thrombopoietin receptor	1p34
842	CASP9	APAF-3 \| APAF3 \| ICE-LAP6 \| MCH6 \| PPP1R56	caspase 9	1p36.21
3570	IL6R	CD126 \| IL-6R-1 \| IL-6RA \| IL6Q \| IL6RA \| IL6RQ \| gp80	interleukin 6 receptor	1q21
5287	PIK3C2B	C2-PI3K	phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta	1q32
9139	CBFA2T2	EHT \| MTGR1 \| ZMYND3 \| p85	core-binding factor, runt domain, alpha subunit 2; translocated to, 2	20q11
5155	PDGFB	IBGC5 \| PDGF-2 \| PDGF2 \| SIS \| SSV \| c-sis	platelet derived growth factor subunit B	22q13.1
3554	IL1R1	CD121A \| D2S1473 \| IL-1R-alpha \| IL1R \| IL1RA \| P80	interleukin 1 receptor type 1	2q12
3553	IL1B	IL-1 \| IL1-BETA \| IL1F2	interleukin 1 beta	2q14
7852	CXCR4	CD184 \| D2S201E \| FB22 \| HM89 \| HSY3RR \| LAP-3 \| LAP3 \| LCR1 \| LESTR \| NPY3R \| NPYR \| NPYRL \| NPYY3R \| WHIM \| WHIMS	C-X-C motif chemokine receptor 4	2q21
6772	STAT1	CANDF7 \| IMD31A \| IMD31B \| IMD31C \| ISGF-3 \| STAT91	signal transducer and activator of transcription 1	2q32.2
2815	GP9	CD42a \| GPIX	glycoprotein IX platelet	3q21.3
2624	GATA2	DCML \| IMD21 \| MONOMAC \| NFE1B	GATA binding protein 2	3q21.3
2122	MECOM	AML1-EVI-1 \| EVI1 \| MDS1 \| MDS1-EVI1 \| PRDM3 \| RUSAT2	MDS1 and EVI1 complex locus	3q26.2
3815	KIT	C-Kit \| CD117 \| PBT \| SCFR	KIT proto-oncogene receptor tyrosine kinase	4q12
2919	CXCL1	FSP \| GRO1 \| GROa \| MGSA \| MGSA-a \| NAP-3 \| SCYB1	C-X-C motif chemokine ligand 1	4q21
56034	PDGFC	FALLOTEIN \| SCDGF	platelet derived growth factor C	4q32
836	CASP3	CPP32 \| CPP32B \| SCA-1	caspase 3	4q34
5921	RASA1	CM-AVM \| CMAVM \| GAP \| PKWS \| RASA \| RASGAP \| p120 \| p120GAP \| p120RASGAP	RAS p21 protein activator 1	5q13.3
7422	VEGFA	MVCD1 \| VEGF \| VPF	vascular endothelial growth factor A	6p12
896	CCND3	-	cyclin D3	6p21
578	BAK1	BAK \| BAK-LIKE \| BCL2L7 \| CDN1	BCL2 antagonist/killer 1	6p21.3
1432	MAPK14	CSBP \| CSBP1 \| CSBP2 \| CSPB1 \| EXIP \| Mxi2 \| PRKM14 \| PRKM15 \| RK \| SAPK2A \| p38 \| p38ALPHA	mitogen-activated protein kinase 14	6p21.3-p21.2
3720	JARID2	JMJ	jumonji and AT-rich interaction domain containing 2	6p24-p23
4602	MYB	Cmyb \| c-myb \| c-myb_CDS \| efg	MYB proto-oncogene, transcription factor	6q22-q23
3569	IL6	BSF-2 \| BSF2 \| CDF \| HGF \| HSF \| IFN-beta-2 \| IFNB2 \| IL-6	interleukin 6	7p21
5154	PDGFA	PDGF-A \| PDGF1	platelet derived growth factor subunit A	7p22
9134	CCNE2	CYCE2	cyclin E2	8q22.1
4609	MYC	MRTL \| MYCC \| bHLHe39 \| c-Myc	v-myc avian myelocytomatosis viral oncogene homolog	8q24.21
1029	CDKN2A	ARF \| CDK4I \| CDKN2 \| CMM2 \| INK4 \| INK4A \| MLM \| MTS-1 \| MTS1 \| P14 \| P14ARF \| P16 \| P16-INK4A \| P16INK4 \| P16INK4A \| P19 \| P19ARF \| TP16	cyclin-dependent kinase inhibitor 2A	9p21
3717	JAK2	JTK10 \| THCYT3	Janus kinase 2	9p24
3563	IL3RA	CD123 \| IL3R \| IL3RAY \| IL3RX \| IL3RY \| hIL-3Ra	interleukin 3 receptor subunit alpha	Xp22.3 or Yp11.3